Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis

Mathematical Biosciences and Engineering

Volumn 8, Issue 2, 2011, Pages 355-369

  Schättler, Heinz ^a   Ledzewicz, Urszula ^b   Cardwell, Benjamin ^b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

Optimal control; Singular arcs; Synthesis; Tumor anti angiogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; COMPUTER ASSISTED DRUG THERAPY; COMPUTER SIMULATION; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; HUMAN; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMPUTER-ASSISTED; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME;

EID: 79955020103     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2011.8.355     Document Type: Conference Paper

References (24)

1. T. Boehm, J. Folkman, T. Browder and M. S. O'Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance, Nature, 390(1997), 404-407. (Pubitemid 28027321)
2. B. Bonnard and M. Chyba, "Singular Trajectories and Their Role in Control Theory", Springer Verlag, Paris, 2003
3. A. Bressan and B. Piccoli, "Introduction to the Mathematical Theory of Control", American Institute of Mathematical Sciences, 2007.
4. S. Davis and G. D. Yancopoulos, The angiopoietins: Yin and Yang in angiogenesis, Current Topics in Microbiology and Immunology, 237(1999), 173-185. (Pubitemid 28554864)
5. A. d'Onofrio and A. Gandolfi, Tumour eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999), Mathematical Biosciences, 191(2004), 159-184. (Pubitemid 39195231)
6. A. Ergun, K. Camphausen and L. M. Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors, Bulletin of Mathematical Biology, 65(2003), 407-424. (Pubitemid 36521826)
7. J. Folkman, Antiangiogenesis: New concept for therapy of solid tumors, Annals of Surgery, 175(1972), 409-416.
8. J. Folkman, Angiogenesis inhibitors generated by tumors, Mol. Med., 1(1995), 120-122.
9. P. Hahnfeldt, D. Panigrahy, J. Folkman and L. Hlatky, Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy, Cancer Research, 59(1999), 4770-4775. (Pubitemid 29472873)
10. R. K. Jain, Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy, Nature Medicine, 7(2001), 987-989. (Pubitemid 32937367)
11. R. K. Jain and L. L. Munn, Vascular normalization as a rationale for combining chemotherapy with antiangiogenic agents, Principles of Practical Oncology, 21(2007), 1-7.
12. M. Klagsburn and S. Soker, VEGF/VPF: The angiogenesis factor found?, Current Biology, 3(1993), 699-702.
13. R. S. Kerbel, A cancer therapy resistant to resistance, Nature, 390(1997), 335-336. (Pubitemid 28027292)
14. U. Ledzewicz, J. Marriott, H. Maurer and H. Schättler, Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment, Mathematical Medicine and Biology, 27(2010), 157-179.
15. U. Ledzewicz, J. Munden and H. Schättler, Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models, Discrete and Continuous Dynamical Systems, Series B, 12(2009), 415-438.
16. U. Ledzewicz and H. Schättler, A synthesis of optimal controls for a model of tumor growth under angiogenic inhibitors, Proc. 44th IEEE Conference on Decision and Control, Sevilla, Spain, (2005), 934-939. (Pubitemid 46297087)
17. U. Ledzewicz and H. Schättler, Anti-angiogenic therapy in cancer treatment as an optimal control problem, SIAM J. on Control and Optimization, 46(2007), 1052-1079.
18. U. Ledzewicz and H. Schättler, Analysis of a mathematical model for tumor anti-angiogenesis, Optimal Control Applications and Methods, 29(2008), 41-57. (Pubitemid 351354223)
19. U. Ledzewicz and H. Schättler, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis, J. of Theoretical Biology, 252(2008), 295-312.
20. L. Norton and R. Simon, Growth curve of an experimental solid tumor following radiotherapy, J.of the National Cancer Institute, 58(1977), 1735-1741. (Pubitemid 8118751)
21. L. Norton, A Gompertzian model of human breast cancer growth, Cancer Research, 48(1988), 7067-7071. (Pubitemid 19013983)
22. L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze and E. F. Mishchenko, "The Mathematical Theory of Optimal Processes", MacMillan, New York, 1964.
23. A. Swierniak, Direct and indirect control of cancer populations, Bulletin of the Polish Academy of Sciences, Technical Sciences, 56(2008), 367-378.
24. A. Swierniak, Comparison of six models of antiangiogenic therapy, Applied Mathematics, 36(2009), 333-348.